Prospective study of the incidence, timing, significance, risk factors, and outcome of cytomegalovirus infection in liver transplant patients with double-drug immunosuppression and no prophylactic antiviral therapy.
Sanchez-Turrión
V
V
Hospital Puerta de Hierro, Madrid, Spain.
Cuervas-Mons
V
V
Portero
F
F
Barrios
C
C
Garrido
A
A
Albillos
A
A
D000328:Adult; D000914:Antibodies, Viral / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology*; D004359:Drug Therapy, Combination; D015774:Ganciclovir / Q000627:therapeutic use; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D015994:Incidence; D016031:Liver Transplantation / Q000276:immunology*; D011241:Prednisone / Q000627:therapeutic use*; D011379:Prognosis; D011446:Prospective Studies; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
D000914:Antibodies, Viral; D016572:Cyclosporine; D015774:Ganciclovir; D011241:Prednisone